Page last updated: 2024-10-26

edrophonium and Arrhythmogenic Right Ventricular Cardiomyopathy

edrophonium has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research Excerpts

ExcerptRelevanceReference
" In the 12 patients with structural heart disease (including two with arrhythmogenic right ventricular dysplasia), adenosine (260 to 550 microg/kg) failed to slow or terminate VT."3.70Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects. ( Lerman, BB; Markowitz, SM; Mittal, S; Slotwiner, D; Stein, KM, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerman, BB1
Stein, KM1
Markowitz, SM1
Mittal, S1
Slotwiner, D1

Other Studies

1 other study available for edrophonium and Arrhythmogenic Right Ventricular Cardiomyopathy

ArticleYear
Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects.
    Journal of cardiovascular electrophysiology, 1999, Volume: 10, Issue:1

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular

1999